Company Search:
Advanced Search
Sponsored Links
Retrophin Inc Company Snapshot
Retrophin Inc operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Retrophin Inc with three other companies in this sector in UNITED STATES : Xencor Inc (2019 sales of $156.70 million of which 72% was Licensing), Tilray Inc ($166.98 million of which 50% was Dried cannabis), and Amicus Therapeutics, Inc ($182.24 million of which 100% was Biopharmaceutical).

Sales Analysis. During the year ended December of 2019, sales at Retrophin Inc were $175.34 million. This is an increase of 6.8% versus 2018, when the company's sales were $164.25 million. This was the fifth consecutive year of sales increases at Retrophin Inc (and since 2014, sales have increased a total of 522%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Retrophin Inc
  Stock Performance Chart for Retrophin Inc
  Stock Data: Recent Stock Performance:
  Current Price (9/18/2020): 20.25
(Figures in U.S. Dollars)
1 Week 9.4%   13 Weeks 9.3%  
4 Weeks 28.2%   52 Weeks 61.4%  
Retrophin Inc Key Data:
  Ticker: RTRX Country: United States
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 175,338,000
(Year Ending Jan 2020).
Employees: 221
  Currency: U.S. Dollars Market Cap: 1,030,783,199
  Fiscal Yr Ends: December Shares Outstanding: 50,902,874
  Share Type: Common Closely Held Shares: 5,908,044
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.